Back to DE D. E. Shaw & Co., Inc.

COGTCOGT
19 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in Cogent Biosciences, Inc.

D. E. Shaw & Co., Inc. holds 922,479 shares of COGT (Cogent Biosciences, Inc.), worth $35.7M as of 2026-Q2. The position was decreased (-50.6% shares). COGT represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$35.7M

Current Shares

922,479

Total Value Change

+$35.5M

Total Shares Change

+896,666

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
922,479
-50.6%
$35.7M0.0%$38.70
0
2026-Q1
Decreased
1.9M
-16.9%
$71.9M0.0%$37.24
0
2025-Q4
Increased
2.2M
+46.8%
$79.8M0.0%$37.12
41
2025-Q3
Increased
1.5M
+459.7%
$22M0.0%$14.13
46
2025-Q2
Increased
273,535
+25.8%
$2M0.0%$7.10
32
2025-Q1
Decreased
217,531
-36.0%
$1.3M0.0%$6.48
0
2024-Q4
Decreased
339,988
-25.6%
$2.7M0.0%$7.71
0
2024-Q3
Increased
457,228
+53.1%
$4.9M0.0%$10.90
38
2024-Q2
Decreased
298,711
-33.8%
$2.5M0.0%$8.43
0
2024-Q1
Increased
451,232
+667.4%
$3M0.0%$6.72
43
2023-Q4
Decreased
58,801
-46.8%
$345,7500.0%$5.88
0
2023-Q3
Decreased
110,526
-45.3%
$1.1M0.0%$9.75
0
2023-Q2
Decreased
202,156
-56.2%
$2.4M0.0%$11.57
0
2023-Q1
Decreased
461,834
-37.0%
$5M0.0%$10.43
0
2022-Q4
Decreased
733,460
-18.5%
$8.5M0.0%$11.56
0
2022-Q3
Increased
900,073
+359.4%
$13.4M0.0%$14.40
45
2022-Q2
New
195,901
-
$1.8M0.0%$8.87
36
2022-Q1
Exited
0
-100.0%
$00.0%$7.52
0
2021-Q4
New
25,813
-
$221,0000.0%$8.56
32

Other major holders of COGT: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used